First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study by Ning Li, Jin Xia, Xiaohui Gao, Jianwei Zhou, Yonggui Hong, Donghai Cui, Xuesong Zhao, Tao Wu, Yanzhen Guo, Junsheng Wang, Suxia Luo

Get full text

Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD‐1 and VEGF, in Chinese Patients With Advanced Solid Tumors by Fenghua Wang, Xiaoli Wei, Yulong Zheng, Jing Wang, Jieer Ying, Xiaozhong Chen, Suxia Luo, Huiyan Luo, Xufang Yu, Benchao Chen, Lei Ma, Ruihua Xu

Get full text

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial by Lu Zhang, Shu Li, Jing Huang, Yan Wu, Liang Han, Tian Gao, Qingxia Fan, Suxia Luo, Binlei Liu, Lixin Zhou, Xinyu Wang, Ling Jia, Jianhua Shi, Zhichao Tan, Zhengfu Fan, Sijuan Ding, Chujie Bai, Ruifeng Xue, Jiayong Liu

Get full text

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a... by Dan Liu, Jifang Gong, Jian Li, Changsong Qi, Zuoxing Niu, Bo Liu, Zhi Peng, Suxia Luo, Xicheng Wang, Yakun Wang, Rusen Zhao, Lilin Chen, Ting Deng, Zhen Li, Lei Chen, Meimei Fang, Hongwei Yang, Linzhi Lu, Yanming Zhang, Fengling Kang, Ting Xu, Xiaotian Zhang, Lin Shen

Get full text